SOBOL PHILIP A 4
4 · Entia Biosciences, Inc. · Filed Jun 19, 2012
Insider Transaction Report
Form 4
SOBOL PHILIP A
Director
Transactions
- Award
Series A Preferred Stock
2012-05-18$5.00/sh+5,000$25,000→ 5,000 total(indirect: By Trust)Exercise: $0.50From: 2012-05-18→ Common Stock (50,000 underlying) - Award
Convertible Promissory Note
2012-05-18$25000.00/sh+1$25,000→ 1 totalExercise: $5.00From: 2012-05-18Exp: 2012-12-31→ Series A Preferred Stock - Award
Common Stock Purchase Warrant
2012-05-18+150,000→ 150,000 total(indirect: By Trust)Exercise: $0.55From: 2012-05-18Exp: 2017-05-17→ Common Stock (150,000 underlying)
Footnotes (3)
- [F1]The conversion price is adjustable pursuant to certain anti-dilution provisions.
- [F2]The preferred shares are convertible into common shares at any time,but under certain circumstances there could be a mandatory conversion, as for example after the annivesary of the effectiveness of a registration statement covering the common stock underlying the preferred shares or within 30 days of the closing of a private placement exceeding $5 million.
- [F3]These warrants were issued as an incentive for making a loan. No valuation or pricing of the warrants has been done.